Create Free Account

By creating account you will get access to hot stocks & personalised emails

Ecofibre Ltd

Healthcare AU EOF

0.055AUD
0.002(3.77%)

Last update at 2024-05-20T01:04:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.050.24
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -29.90600M -21.74800M -10.04300M 17.25M 4.58M
Minority interest - - - - -
Net income -39.91300M -14.67000M -6.98600M 13.16M 6.00M
Selling general administrative 16.43M 16.00M 16.43M 14.98M 14.99M
Selling and marketing expenses 1.32M 2.26M 1.90M 2.87M 1.65M
Gross profit 17.28M 14.69M 17.62M 38.46M 25.77M
Reconciled depreciation 4.74M 5.07M 4.29M 2.05M 0.96M
Ebit -21.16700M -20.36800M -8.84200M 17.39M 4.96M
Ebitda -16.42800M -15.29500M -4.55200M 19.44M 5.92M
Depreciation and amortization 4.74M 5.07M 4.29M 2.05M 0.96M
Non operating income net other - - - - -
Operating income -24.63200M -22.51200M -13.79300M 10.91M 4.96M
Other operating expenses 13.58M 17.57M 13.54M 8.35M 32.51M
Interest expense 2.92M 1.38M 1.20M 0.14M 0.37M
Tax provision 10.01M -7.07800M -3.05700M 4.09M -1.41500M
Interest income 2.92M 0.00100M 1.20M 0.14M 0.37M
Net interest income -2.76000M -1.37900M -1.17300M -0.14400M -0.37200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 10.01M -7.07800M -3.05700M 4.09M -1.41500M
Total revenue 32.51M 30.22M 28.79M 50.72M 35.60M
Total operating expenses 41.91M 37.21M 31.42M 27.55M 22.68M
Cost of revenue 15.23M 15.53M 11.17M 12.26M 9.83M
Total other income expense net -2.51400M 2.14M 4.92M 6.22M -0.37200M
Discontinued operations - - - - -
Net income from continuing ops -39.91300M -14.67000M -6.98600M 13.16M 6.00M
Net income applicable to common shares -39.91300M -14.67000M -6.98600M 13.16M 6.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 118.73M 149.55M 141.75M 84.30M 47.77M
Intangible assets 0.61M 4.28M 3.88M 0.66M 0.34M
Earning assets - - - - -
Other current assets 1.31M 5.67M 6.34M 7.75M 3.37M
Total liab 44.09M 39.61M 29.95M 21.29M 5.47M
Total stockholder equity 74.63M 109.94M 111.80M 63.00M 42.30M
Deferred long term liab - - - - -
Other current liab 4.46M 5.92M 3.64M 9.67M 2.94M
Common stock 116.54M 115.35M 108.13M 62.38M 56.19M
Capital stock 116.54M 115.35M 108.13M 62.38M 56.19M
Retained earnings -65.91700M -26.00400M -11.33400M -4.34800M -17.50400M
Other liab 11.93M 14.31M 13.69M - 0.39M
Good will 53.07M 51.09M 46.77M 46.77M -
Other assets 0.00000M 9.67M 3.91M 2.49M 2.03M
Cash 7.29M 7.25M 8.62M 18.25M 25.74M
Cash and equivalents - 7.25M - - -
Total current liabilities 6.46M 8.07M 5.72M 10.70M 5.08M
Current deferred revenue -4.44700M -5.88500M -3.57900M -8.84300M -
Net debt 19.75M 12.46M 2.41M -7.16800M -24.40000M
Short term debt 1.33M 2.48M 0.49M 0.49M 1.34M
Short long term debt 1.00M 2.01M - - 1.34M
Short long term debt total 27.03M 19.71M 11.03M 11.08M 1.34M
Other stockholder equity -50.62100M -89.34300M -96.79800M -58.02800M 3.62M
Property plant equipment 43.43M 47.83M 47.99M 35.68M 6.66M
Total current assets 21.63M 36.69M 39.21M 45.46M 38.75M
Long term investments - - - - -
Net tangible assets 20.95M 54.57M 61.16M 62.34M 41.96M
Short term investments 0.35M 0.20M 4.28M 14.13M 23.43M
Net receivables 2.88M 4.13M 4.48M 9.44M 2.81M
Long term debt 25.61M 16.77M 10.06M 10.00M 0.00000M
Inventory 9.38M 15.70M 16.41M 10.01M 6.57M
Accounts payable 5.11M 5.56M 5.16M 9.38M 3.74M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 24.01M 20.60M 15.00M 4.97M 3.62M
Additional paid in capital - - - - -
Common stock total equity - - - 62.38M 56.19M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -97.10600M -103.19700M -98.63300M -36.34000M 9.03M
Deferred long term asset charges - - - - -
Non current assets total 97.11M 112.87M 102.54M 38.83M 9.03M
Capital lease obligations 0.43M 0.93M 0.96M 1.08M -
Long term debt total 25.70M 17.23M 10.54M 10.59M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -1.58000M -2.99600M -28.73800M -22.52800M -4.68700M
Change to liabilities 9.61M -6.64400M 0.91M -0.47700M -1.31200M
Total cashflows from investing activities -1.58000M -2.99600M -28.73800M -22.52800M -4.68700M
Net borrowings 6.76M 8.18M -0.53400M 9.40M -1.17300M
Total cash from financing activities 7.64M 12.46M 28.57M 9.40M 25.11M
Change to operating activities -1.86400M 1.84M 1.55M -1.92200M -1.70200M
Net income -39.91300M -14.67000M -6.98600M 13.16M 6.00M
Change in cash 0.04M -1.36900M -9.63200M -7.48800M 22.98M
Begin period cash flow 7.25M 8.62M 18.25M 25.74M 2.76M
End period cash flow 7.29M 7.25M 8.62M 18.25M 25.74M
Total cash from operating activities -6.91000M -10.59500M -8.35800M 5.81M 2.44M
Issuance of capital stock 0.87M 4.28M 29.50M - 27.32M
Depreciation 4.55M 4.74M 4.11M 1.99M 0.96M
Other cashflows from investing activities 0.13M -0.00900M 0.06M -0.12600M 0.25M
Dividends paid - - - - 0.60M
Change to inventory 6.32M 0.71M -6.39900M -3.44100M -3.85400M
Change to account receivables 4.16M 0.38M 5.17M -6.83700M -1.86500M
Sale purchase of stock 0.87M 4.28M 29.50M 0.00000M -1.04000M
Other cashflows from financing activities 8.77M 8.71M -0.39200M 10.00M 0.60M
Change to netincome 6.16M -0.99800M -2.77100M 2.20M 3.79M
Capital expenditures 1.21M 2.67M 6.11M 22.61M 5.17M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 10.49M 1.09M -1.23000M -10.27800M 1.59M
Stock based compensation 0.68M 1.67M 1.77M 2.71M -
Other non cash items 28.46M -0.66500M -5.47900M -9.33900M -6.95800M
Free cash flow -8.12300M -13.26800M -14.46300M -16.79600M -2.73600M

Fundamentals

  • Previous Close 0.05
  • Market Cap18.94M
  • Volume4342
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-16.33100M
  • Revenue TTM29.67M
  • Revenue Per Share TTM0.09
  • Gross Profit TTM 9.47M
  • Diluted EPS TTM-0.19

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EOF
Ecofibre Ltd		 0.002 3.77% 0.06 - 37.74 0.89 0.87 1.73 -1.1438
AFP
AFT Pharmaceuticals Ltd		 - -% 2.46 27.33 17.06 1.79 4.41 2.18 16.66
PBP
Probiotec Ltd		 0.01 0.34% 2.93 29.20 - 1.06 2.64 1.39 8.58
VLS
Vita Life Sciences Ltd		 0.02 0.93% 2.17 12.88 - 1.73 2.97 1.41 7.98
NXS
Next Science Ltd		 -0.023 7.30% 0.29 - 128.21 4.47 5.03 3.90 -5.9908

Reports Covered

Stock Research & News

View All

Profile

Ecofibre Limited, together with its subsidiaries, engages in the researching, producing, and selling of polymer-based industrial products and hemp derived nutraceuticals and food in the United States and Australia. The company operates through three segments: Ananda Health, Ananda Food, and Hemp Black. It offers cannabinoid based health products for human and pet consumption; hemp related food products; and textile and hemp products. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.

Ecofibre Ltd

680 George Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Eric Wang CEO, MD & Director NA
Mr. Jonathan Brown CFO & Joint Company Sec. NA
Dr. Alex Capano Chief Science Officer NA
Ms. Robin Sheldon Gen. Counsel & Joint Company Sec. NA
Mr. Kieren Brown Managing Director of Ananda Food NA
Mary Jakobi US Financial Controller NA
Kate Douglass Group Financial Controller NA
Mr. Jeff Bruner Pres of Hemp Black NA
Mr. Alex Nance Pres of Ananda Health NA
Ms. Vanessa Miscamble Wallace B.Comm (UNSW), MAICD, MBA Interim CEO, Interim MD & Chairman 1963

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.